Bicycle Therapeutics Plc - ADR
BCYC
Market Cap$511.09M
Close$
$-2.25
131.5% downside
Current Fair Value
131.5% downsideOvervalued by 131.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $511.09 Million |
|---|---|
| Enterprise Value | $-183,106,893.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-2.91 |
| Beta | 1.45 |
| Outstanding Shares | 69,252,009 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -2.11 |
|---|---|
| PEG | -2.15 |
| Price to Sales | - |
| Price to Book Ratio | 0.8 |
| Enterprise Value to Revenue | -9.5 |
| Enterprise Value to EBIT | 0.71 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.15 |
| Debt to Equity | 0.04 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Bicycle Therapeutics Plc
CEO: Kevin Lee